Govt approves procurement of 150,000 units of DRDO's 'Oxycare' system

The government approved the procurement of 1,50,000 units of 'Oxycare' system developed by the Defence Research and Development Organisation to help in the treatment of Covid patients

DRDO's 'Oxycare' system
DRDO's 'Oxycare' system. Photo: @DRDO_India
Press Trust of India New Delhi
2 min read Last Updated : May 12 2021 | 4:40 PM IST

The government on Wednesday approved the procurement of 1,50,000 units of 'Oxycare' system developed by the Defence Research and Development Organisation (DRDO) to help in the treatment of COVID-19 patients.

Oxycare is an oxygen supply system based on SpO2 (oxygen saturation) level. The DRDO has already transferred the technology to multiple industries in India for large-scale production of the Oxycare system.

The 'Oxycare' systems will be procured for Rs 322.5 crore using the PM-Cares Fund, according to the defence ministry.

"PM-Cares Fund has accorded sanction for procurement of 1,50,000 units of 'Oxycare' system developed by the DRDO at a cost of Rs 322.5 crore," it said.

The ministry said 1,00,000 manual and 50,000 automatic Oxycare systems are being procured.

"The Oxycare system delivers supplemental oxygen based on the SpO2 levels and prevents a person from sinking into a state of hypoxia which can be fatal," the ministry said in a statement.

Oxycare was developed by the DRDO's Bengaluru-based Defence Bio-Engineering and Electro Medical Laboratory (DEBEL) for soldiers posted at extreme high-altitude areas.

"The system is indigenously developed for operation in field conditions and is robust. It can be effectively used to treat COVID-19 patients," the ministry said.

It said the variants of the system have been configured.

"The basic version consists of a 10-litre oxygen cylinder, a pressure regulator cum flow controller, a humidifier and a nasal cannula. The oxygen flow is regulated manually based on the SpO2 readings," the ministry said.

"In the second configuration, the oxygen cylinder is equipped with electronic controls which automatically regulate the oxygen flow through a low-pressure regulator and an SpO2 probe," it said.

Various parts of India have been ravaged by a devastating second wave of coronavirus pandemic. One of the most common complications being faced by the COVID-19 patients has been a drop in oxygen levels.

The huge surge in coronavirus cases has triggered a shortage of medical oxygen across the country.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :DRDOCoronavirusOxygencentral government

First Published: May 12 2021 | 4:33 PM IST

Next Story